Arkos Global Advisors’s Abbott ABT Stock Holding History

Arkos Global Advisors’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,804	Closed	-$509K	–	127
2025 Q3	$509K	Buy	+3,804	New	+$499K	0.06%	86

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Arkos Global Advisors's ABT Position: Q4 2025 in Review

Arkos Global Advisors sold out of Abbott (ABT) in Q4 2025, closing a stake of 3,804 shares — an estimated $509K sold.

Arkos Global Advisors first reported a position in ABT in Q3 2025 and held it in 1 quarter. The position peaked at $509K in Q3 2025. 3,284 funds tracked by Wall St. Rank hold ABT as of Q4 2025.

Arkos Global Advisors reported no remaining Abbott position as of Q4 2025 after selling out during the quarter.
Arkos Global Advisors sold 3,804 Abbott shares in Q4 2025, an estimated $509K.
Arkos Global Advisors first reported a position in Abbott in Q3 2025 and held it in 1 quarter.
Arkos Global Advisors's Abbott position peaked at $509K in Q3 2025.
3,284 funds tracked by Wall St. Rank held Abbott as of Q4 2025.

Based on Arkos Global Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.